Owen LaRue LLC purchased a new position in shares of CME Group Inc. (NASDAQ:CME - Free Report) in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm purchased 8,273 shares of the financial services provider's stock, valued at approximately $2,280,000.
Other hedge funds and other institutional investors also recently made changes to their positions in the company. Great Lakes Advisors LLC grew its position in CME Group by 2.3% in the first quarter. Great Lakes Advisors LLC now owns 1,661 shares of the financial services provider's stock valued at $441,000 after purchasing an additional 37 shares in the last quarter. SeaCrest Wealth Management LLC grew its holdings in shares of CME Group by 3.0% in the 1st quarter. SeaCrest Wealth Management LLC now owns 1,379 shares of the financial services provider's stock valued at $366,000 after acquiring an additional 40 shares in the last quarter. OneAscent Financial Services LLC increased its position in shares of CME Group by 4.0% in the first quarter. OneAscent Financial Services LLC now owns 1,106 shares of the financial services provider's stock valued at $293,000 after acquiring an additional 43 shares during the last quarter. Lantz Financial LLC raised its holdings in CME Group by 1.1% during the second quarter. Lantz Financial LLC now owns 3,932 shares of the financial services provider's stock worth $1,084,000 after acquiring an additional 44 shares in the last quarter. Finally, Ballentine Partners LLC raised its holdings in CME Group by 0.8% during the first quarter. Ballentine Partners LLC now owns 5,828 shares of the financial services provider's stock worth $1,546,000 after acquiring an additional 45 shares in the last quarter. 87.75% of the stock is currently owned by institutional investors and hedge funds.
Insider Transactions at CME Group
In related news, insider Sunil Cutinho sold 11,896 shares of CME Group stock in a transaction that occurred on Tuesday, August 26th. The stock was sold at an average price of $271.47, for a total transaction of $3,229,407.12. Following the completion of the sale, the insider directly owned 17,440 shares of the company's stock, valued at approximately $4,734,436.80. This trade represents a 40.55% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, General Counsel Jonathan L. Marcus sold 392 shares of the business's stock in a transaction on Thursday, September 18th. The shares were sold at an average price of $262.00, for a total value of $102,704.00. Following the completion of the sale, the general counsel owned 7,851 shares of the company's stock, valued at $2,056,962. This trade represents a 4.76% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 13,043 shares of company stock worth $3,527,956 over the last quarter. Company insiders own 0.30% of the company's stock.
CME Group Trading Up 1.6%
CME stock opened at $268.73 on Friday. CME Group Inc. has a one year low of $213.94 and a one year high of $290.79. The stock has a market cap of $96.84 billion, a price-to-earnings ratio of 26.01, a price-to-earnings-growth ratio of 4.79 and a beta of 0.43. The company has a fifty day moving average price of $270.96 and a two-hundred day moving average price of $270.80. The company has a debt-to-equity ratio of 0.12, a current ratio of 1.02 and a quick ratio of 1.02.
CME Group (NASDAQ:CME - Get Free Report) last issued its quarterly earnings data on Wednesday, July 23rd. The financial services provider reported $2.96 earnings per share for the quarter, beating the consensus estimate of $2.91 by $0.05. The company had revenue of $1.69 billion for the quarter, compared to analyst estimates of $1.68 billion. CME Group had a net margin of 58.48% and a return on equity of 14.60%. The company's revenue was up 10.4% on a year-over-year basis. During the same period in the prior year, the firm earned $2.56 earnings per share. Equities analysts anticipate that CME Group Inc. will post 10.49 EPS for the current year.
CME Group Announces Dividend
The business also recently disclosed a quarterly dividend, which was paid on Thursday, September 25th. Shareholders of record on Tuesday, September 9th were given a dividend of $1.25 per share. The ex-dividend date was Tuesday, September 9th. This represents a $5.00 annualized dividend and a yield of 1.9%. CME Group's dividend payout ratio (DPR) is 48.40%.
Analyst Upgrades and Downgrades
A number of research analysts have weighed in on the company. JPMorgan Chase & Co. raised their price target on CME Group from $246.00 to $252.00 and gave the company an "underweight" rating in a research note on Thursday. Oppenheimer boosted their target price on shares of CME Group from $300.00 to $303.00 and gave the stock an "outperform" rating in a report on Thursday, July 24th. UBS Group dropped their price target on shares of CME Group from $305.00 to $285.00 and set a "neutral" rating on the stock in a research report on Monday, September 8th. Piper Sandler lifted their price objective on shares of CME Group from $283.00 to $296.00 and gave the company an "overweight" rating in a research report on Tuesday, July 15th. Finally, Citigroup raised shares of CME Group from a "neutral" rating to a "buy" rating and upped their target price for the company from $275.00 to $300.00 in a report on Thursday. Five analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and three have issued a Sell rating to the company. According to data from MarketBeat.com, the company has an average rating of "Hold" and a consensus price target of $268.14.
Check Out Our Latest Research Report on CME Group
CME Group Profile
(
Free Report)
CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.
Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider CME Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CME Group wasn't on the list.
While CME Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.